Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA4 | P22748 | 1/20 | 0.39 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.36 |
| ▸ | PEPD | P12955 | 1/20 | 0.35 |
| ▸ | GRM8 | O00222 | 1/20 | 0.35 |
| ▸ | GRM6 | O15303 | 1/20 | 0.35 |
| ▸ | GRM7 | Q14831 | 1/20 | 0.35 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL771739 | 1.00 | CA4 (0.39) | CA4FOLH1PEPDGRM8GRM6 | |
| SCHEMBL4297049 | 1.00 | CA4 (0.39) | CA4FOLH1PEPDGRM8GRM6 | |
| SCHEMBL28006119 | 0.98 | CA4 (0.38) | CA4FOLH1PEPDGRM8GRM6 | |
| Aspartic Acid SCHEMBL4775933 | 0.94 | GRM8 (0.40) | FOLH1GRM8GRM6GRM7GRM4 | |
| Aspartic Acid SCHEMBL27759943 | 0.94 | GRM8 (0.40) | FOLH1GRM8GRM6GRM7GRM4 | |
| SCHEMBL28278353 | 0.94 | CA4 (0.40) | CA4FOLH1PEPDGRM8GRM6 | |
| SCHEMBL1890693 | 0.86 | FOLH1 (0.35) | FOLH1GRM8GRM6GRM7GRM4 | |
| Phosphoramidic Acid SCHEMBL1691899 | 0.84 | FOLH1 (0.34) | FOLH1GRM8GRM6GRM7GRM4 | |
| Phosphoramidic Acid SCHEMBL13280710 | 0.84 | FOLH1 (0.34) | FOLH1GRM8GRM6GRM7GRM4 | |
| SCHEMBL1890700 | 0.83 | FOLH1 (0.32) | FOLH1GRM8GRM6GRM7GRM4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 321 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220260583-A1 | CHEMOPROTEOMIC PROFILING OF PROTEIN ELECTROPHILIC AND OXIDATIVE POST-TRANSLATIONAL MODIFICATIONS | Zenagem, LLC | 2022-08-18 | — | — | US | claimed |
| US-11226337-B2 | Chemoproteomic profiling of protein electrophilic and oxidative post-translational modifications | Zenagem, LLC (US) | 2022-01-18 | — | — | US | claimed |
| US-20190204336-A1 | CHEMOPROTEOMIC PROFILING OF PROTEIN ELECTROPHILIC AND OXIDATIVE POST-TRANSLATIONAL MODIFICATIONS | Zenagem, LLC | 2019-07-04 | — | — | US | claimed |
| EP-2995895-A1 | METHODS AND COMPONENTS FOR THERMAL ENERGY STORAGE | Caloritum NV (BE) | 2016-03-16 | — | — | EP | claimed |
| CN-103384809-B | For method and the component of thermal energy storage | Renewable Energy System Technology (TFRES) SDN BHD (BE) | 2016-01-20 | — | — | CN | claimed |
| EP-2668459-B1 | METHODS AND COMPONENTS FOR THERMAL ENERGY STORAGE | CALORITUM NV (BE) | 2015-10-28 | — | — | EP | claimed |
| US-9163868-B2 | Methods and components for thermal energy storage | TECHNOLOGY FOR RENEWABLE ENERGY SYSTEMS (TFRES) BVBA (BE) | 2015-10-20 | — | — | US | claimed |
| EP-2668459-A1 | METHODS AND COMPONENTS FOR THERMAL ENERGY STORAGE | Technology For Renewable Energy Systems (TFRES) BV (BE) | 2013-12-04 | — | — | EP | claimed |
| US-20130306268-A1 | METHODS AND COMPONENTS FOR THERMAL ENERGY STORAGE | TECHNOLOGY FOR RENEWABLE ENERGY SYSTEMS (TFRES) BVBA (BE) | 2013-11-21 | — | — | US | claimed |
| CN-103384809-A | Methods and components for thermal energy storage | DUCHEYNE WOUTER | 2013-11-06 | — | — | CN | claimed |
| WO-2012101110-A1 | METHODS AND COMPONENTS FOR THERMAL ENERGY STORAGE | TECHNOLOGY FOR RENEWABLE ENERGY SYSTEMS (TFRES) BVBA (BE) | 2012-08-02 | — | — | WO | claimed |
| US-6495356-B1 | BERYLLIUM ATOM IS COMPLEXED WITH FLUORINE LIGANDS IN LIEU OF A PHOSPHATE GROUP AT PHOSPHORYLATION SITE; BEFX REACTS WITH CARBOXYL GROUP TO MIMIC AN ACYL PHOSPHATE LINKAGE; FORMED IN THE SUBSTANTIAL ABSENCE OF A NUCLEOSIDE PHOSPHATE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2002-12-17 | — | — | US | claimed |
| WO-2001040268-A2 | BERYLLOFLUORIDE ANALOGUES OF ACYL PHOSPHATE POLYPEPTIDES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2001-06-07 | — | — | WO | claimed |
| EP-4743585-A1 | METHOD FOR PRODUCING SPERMIDINE | TLL The Longevity Labs GmbH (AT) | 2026-05-20 | — | — | EP | disclosed |
| CN-122059901-A | 1,3, 4-Oxadiazole compound and preparation method and application thereof | 成都大学 | 2026-05-19 | — | — | CN | disclosed |
| EP-3957736-B1 | PRODUCTION OF ODD CHAIN FATTY ACID DERIVATIVES IN RECOMBINANT MICROBIAL CELLS | GENOMATICA INC (US) | 2025-08-06 | — | — | EP | disclosed |
| WO-1993012076-A1 | REAGENTS FOR AUTOMATED SYNTHESIS OF PEPTIDE ANALOGS | CORVAS INTERNATIONAL INC. (US) | 1993-06-24 | — | — | WO | disclosed |
| US-4307192-A | CULTURING ISOPENICILLINS IN CEPHALOSPORIUM | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1981-12-22 | — | — | US | disclosed |
| US-4248966-A | FROM TRIPEPTIDES IN CEPHALOSPORIUM EXTRACT | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1981-02-03 | — | — | US | disclosed |
| US-4178210-A | Accellular synthesis of cephalosporins | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1979-12-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190204336-A1 | CHEMOPROTEOMIC PROFILING OF PROTEIN ELECTROPHILIC AND OXIDATIVE POST-TRANSLATIONAL MODIFICATIONS | PTMS, CHAMP1, STUB1 | CA4 3191/4885FOLH1 2937/4885PEPD 2356/4885 |
| US-11226337-B2 | Chemoproteomic profiling of protein electrophilic and oxidative post-translational modifications | PTMS, CHAMP1, STUB1 | CA4 3191/4885FOLH1 2937/4885PEPD 2356/4885 |
| US-20220260583-A1 | CHEMOPROTEOMIC PROFILING OF PROTEIN ELECTROPHILIC AND OXIDATIVE POST-TRANSLATIONAL MODIFICATIONS | STUB1, PTMS, TMT1A | CA4 3650/4885FOLH1 2603/4885PEPD 2389/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.